TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
1.80
-0.01 (-0.55%)
At close: Aug 15, 2025, 3:59 PM
1.80
-0.28%
After-hours: Aug 15, 2025, 04:10 PM EDT
TScan Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -36.95M | -34.13M | -35.81M | -29.89M | -31.66M | -30.14M | -19.61M | -23M | -24.05M | -22.56M | -18.72M | -16.25M | -15.1M | -16.16M | -14.2M | -15.84M | -10.67M | -7.91M |
Depreciation & Amortization | 698K | 678K | 711K | 1.03M | 1.12M | 1.25M | 1.28M | 1.29M | 1.3M | 1.5M | 1.48M | 1.25M | 1.21M | 1.2M | 1.14M | 1.06M | 661K | 469K |
Stock-Based Compensation | 3.27M | 3.41M | 2.71M | 2.52M | 2.33M | 1.98M | 1.5M | 1.34M | 1.22M | 1.15M | 1.3M | 1.25M | 1.02M | 984K | 784K | 885K | 503K | 344K |
Other Working Capital | 6.94M | -6.94M | 4.28M | -1.3M | 1.79M | -1.7M | -5.56M | 28.67M | -1.08M | -4.38M | -698K | -2.27M | -909K | -6.97M | 356K | -621K | -2.62M | -3.02M |
Other Non-Cash Items | -6.67M | -1.17M | -287K | -1.3M | -191K | 4.65M | 3.97M | 223K | 218K | 214K | 216K | -3.31M | 3.03M | 2.55M | -5.9M | 2.12M | 394K | 1.12M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -4.7M | -235K | n/a | n/a | n/a | n/a | n/a | n/a | 5.9M | n/a | n/a | n/a |
Change in Working Capital | 6.38M | -6.38M | 5.26M | -279K | 2.18M | -2.11M | -6.2M | 28.4M | -711K | -3.88M | -284K | -3.3M | -501K | -6.15M | -2.11M | 258K | -1.19M | -2.86M |
Operating Cash Flow | -33.27M | -37.59M | -27.41M | -27.92M | -26.23M | -29.27M | -23.77M | 8.02M | -22.02M | -23.59M | -16.01M | -17M | -13.37M | -20.12M | -14.38M | -13.64M | -10.7M | -9.96M |
Capital Expenditures | -1.28M | -1.53M | -888K | -1.37M | -862K | -705K | -469K | -1.42M | -420K | -838K | -1.38M | -424K | -1.89M | -531K | -2.21M | -853K | -3.92M | -2.96M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -26.53M | -60.94M | -47.33M | -136.98M | -48.35M | -8.78M | -17.62M | -59.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 76.25M | 76M | 75.51M | 56M | 15.5M | 45.65M | 20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 36.87M | 2.38M | -59.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 48.44M | 13.53M | 27.29M | -82.35M | -33.72M | 36.16M | 1.91M | -61.41M | -420K | -838K | -1.38M | -424K | -1.89M | -531K | -2.21M | -853K | -3.92M | -2.96M |
Debt Repayment | n/a | n/a | 15.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 191K | n/a | n/a | n/a | n/a | n/a | 176K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 116K | -525K | n/a | n/a | 161.59M | 258K | 19K | -66K | 135.68M | n/a | 108K | 29.13M | 31K | 88K | 120K | 90.61M | -686K | -104K |
Financial Cash Flow | 116K | -525K | 45.69M | 1.23M | 161.59M | 258K | 19K | -252K | 135.68M | n/a | 108K | 29.13M | 31K | 88K | 120K | 90.61M | -686K | 99.63M |
Net Cash Flow | 15.29M | -24.58M | 45.57M | -109.04M | 101.65M | 7.15M | -21.83M | -53.65M | 113.23M | -24.43M | -17.28M | 11.7M | -15.23M | -20.57M | -16.47M | 76.11M | -15.3M | 86.71M |
Free Cash Flow | -34.55M | -39.12M | -28.3M | -29.29M | -27.09M | -29.97M | -24.23M | 6.6M | -22.44M | -24.43M | -17.39M | -17.43M | -15.26M | -20.66M | -16.59M | -14.49M | -14.62M | -12.92M |